Início » REFERÊNCIAS

REFERÊNCIAS

  1. Bajekal N, Li TC . Fibroids, infertility and pregnancy wastage. Hum ReprodUpdate. 2000 Nov-Dec;6(6):614-20.
  2. Benecke C, Kruger TF, Siebert TI, Van der Merwe JP, Steyn DW. Effect of fibroids on fertility in patients undergoing assisted re- production. A structured literature review. Gynecol Obstet Invest. 2005;59(4):225–30.
  3. Camanni M, Bonino L, Delpiano EM, Ferrero B, Migliaretti G, Deltetto F. Hysteroscopic management of large symptomatic submucous uterine myomas. J Minim Invasive Gynecol. 2010 Jan-Feb;17(1):59-65.
  4. D’Silva EC, Muda AM, Safiee AI, Ghazali WAHW. Five-Year Lapsed: Review of Laparoscopic Myomectomy versus Open Myomectomy in Putrajaya Hospital. Gynecol Minim Invasive Ther. 2018 Oct-Dec;7(4):161-166.
  5. Desai, Patel P. Fibroids, Infertility and Laparoscopic Myomectomy. J Gynecol
    Endosc Surg. 2011 Jan-Jun;2(1):36–42.
  6. Donnez J, Donnez O, Matule D, Ahrendt HJ, Hudecek R, Zatik J, et al. Long-term
    medical management of uterine fibroids with ulipristal acetate. Fertil Steril. 2016
    Jan;105(1):165-173.e4.
  7. Donnez J, Hudecek R, Donnez O, Matule D, Arhendt HJ, Zatik J, et al. Efficacy and safety of repeated use of ulipristal acetate in uterine fibroids. Fertil Steril. 2015 Feb;103(2):519-27.e3.
  8. Donnez J, Jadoul P. What are the implications of myomas on fertility? A need for a debate? Hum Reprod. 2002 Jun;17(6):1424–30.
  9. Donnez J, Tatarchuk TF, Bouchard P, Puscasiu L, Zakharenko NF, Ivanova T, et al; PEARL I Study Group. Ulipristal acetate versus placebo for fibroid treatment before surgery. N Engl J Med. 2012 Feb 2;366(5):409-20.
  10. Donnez J, Tomaszewski J, Vázquez F, Bouchard P, Lemieszczuk B, Baró F, et al; PEARL II Study Group. Ulipristal acetate versus leuprolide acetate for uterine fibroids. N Engl J Med. 2012 Feb 2;366(5):421-32.
  11. Donnez J, Vázquez F, Tomaszewski J, Nouri K, Bouchard P, Fauser BC, et al; PEARL III and PEARL III Extension Study Group. Long-term treatment of uterine fibroids with ulipristal acetate. Fertil Steril. 2014 Jun;101(6):1565-73. e1-18.
  12. Garnock-Jones KP, Duggan ST. Ulipristal Acetate: A Review in Symptomatic Uterine Fibroids. Drugs. 2017 Oct;77(15):1665-1675.
  13. Khaund A, Lumsden MA. Impact of fibroids on reproductive function. Best Pract Res Clin Obstet Gynaecol. 2008 Aug;22(4):749-60.
  14. Lasmar RB, Lasmar BP, Celeste RK, da Rosa DB, Depes Dde B, Lopes RG. A new system to classify submucous myomas: a Brazilian multicenter study. J Minim Invasive Gynecol. 2012 Sep-Oct;19(5):575-80.
  15. Lasmar RB, Xinmei Z, Indman PD, Celeste RK, Di Spiezio Sardo A. Feasibility of a new system of classification of submucous myomas: a multicenter study. Fertil Steril. 2011 May;95(6):2073-7.
  16. Luyckx M, Squifflet JL, Jadoul P, Votino R, Dolmans MM, Donnez J. First series of 18 pregnancies after ulipristal acetate treatment for uterine fibroids. Fertil Steril. 2014 Nov;102(5):1404-9.
  17. Manyonda I, Sinthamoney E, Belli AM. Controversies and challen- ges in the modern management of uterine fibroids. BJOG. 2004 Feb;111(2):95–102. 18. Murji A, Whitaker L, Chow TL, Sobel ML. Selective progesterone receptor modulators (SPRMs) for uterine fibroids. Cochrane Database Syst Rev. 2017 Apr 26;4:CD010770.
  18. Odejinmi F, Oliver R, Mallick R. Is ulipristal acetate the new drug of choice for the medical management of uterine fibroids? Res ipsa loquitur? Womens Health (Lond). 2017 Nov 1:1745505717740218.
  19. Practice Committee of the American Society for Reproductive Medi- cine. Myomas and reproductive function. Fertil Steril. 2006 Nov;86(5 Suppl 1):S194-9.
  20. Pritts EA. Fibroids and infertility: A systematic review of the evi- dence. Obstet Gynecol Surv. 2001 Aug;56(8):483-91.
  21. Pundir J, El Toukhy T. Uterine cavity assessment prior to IVF. Wom- ens Health (Lond Engl). 2010 Nov;6(6):841-7.
  22. Rackow BW, Arici A. Fibroids and in-vitro fertilization: Which comes first? Curr Opin Obstet Gynecol. 2005 Jun;17(3):225–31.
  23. Ramzy AM1, Sattar M, Amin Y, Mansour RT, Serour GI, Aboulghar MA. Uterine myomata and outcome of assisted reproduction. Hum Reprod. 1998 Jan;13(1):198-202.
  24. Sangkomkamhang US, Lumbiganon P, Laopaiboon M, Mol BW. Progestogens or progestogen-releasing intrauterine systems for uterine fibroids. Cochrane Database Syst Rev. 2013 Feb 28;(2):CD008994.
  25. Somigliana E, Vercellini P, Daguati R, et al. Fibroids and female re- production: A critical analysis of evidence. Hum Reprod Update. 2007 Sep-Oct;13(5):465-76.
  26. Song H, Lu D, Navaratnam K, Shi G. Aromatase inhibitors for uterine fibroids. Cochrane Database Syst Rev. 2013 Oct 23;(10):CD009505.
  27. Yoshino O, Hayashi T, Osuga Y, et al. Decreased pregnancy rate is linked to abnormal uterine peristalsis caused by intramural fibroids. Hum Reprod. 2010 Oct;25(10):2475-9.
  28. Yoshino O, Nishii O, Osuga Y, et al. Myomectomy decreases abnormal uterine peristalsis and increases pregnancy rate. J Minim Invasive Gynecol. 2012 Jan-Feb;19(1):63-7.
Valores e Dúvidas sobre os
Tratamentos
Tire suas dúvida e saibas os valores dos nossos tratamentos